Galli M, Zerboni S, Politi A, De Nittis G, Bonatti R, Jemoli R, Molteni S, Tettamanti F, Ferrari G
Laboratorio di Emodinamica, Ospedale S. Anna, Como.
G Ital Cardiol. 1999 Mar;29(3):261-8.
Although it is superior to thrombolysis, primary PTCA does have some limitations, both in hospital (recurrent ischemia and reinfarction due to reocclusion of the infarct-related artery) and at the six-month follow-up (high rate of late restenosis). Coronary stenting is a promising way of solving some of these problems, even if its use in patients with acute myocardial infarction could prove to be controversial because of intracoronary thrombus. In this study, we propose two procedural strategies in the treatment of the infarct-related artery (IRA): the search for optimal angiographic results after PTCA ("stent-like result"--SLR--with residual stenosis < or = 20%--no dissection--TIMI III flow) or intracoronary stenting when SLR was not obtained after a second inflation.
From December 1995 to May 1998, 200 patients with AMI underwent direct PTCA or rescue PTCA because of failed thrombolysis. There were 143 men and 57 women, mean age 65 (range 36-84). Nineteen patients were in cardiogenic shock and 25 were in Killip class > II. Recanalization of the IRA was achieved in 196 patients (98%). In four patients, it was not possible to cross total occlusion with the guide-wire. SLR post-PTCA was achieved in 40 patients (20%). Stents were placed in 147 patients (75%), with "elective" implantation in 73 lesions because of suboptimal results after PTCA in 41, and early loss or coronary dissection with threatening occlusion in 33. In nine patients without SLR, stenting was not performed because of diffuse disease of the IRA. In-hospital complications included ten deaths (8 of 19 patients with cardiogenic shock at admission and 2 with multivessel disease and severe left ventricular dysfunction). None of the patients required emergency coronary bypass for procedural complications. One patient had a subacute thrombosis on the third day after bail-out stent implantation (re-PTCA). Five patients required elective bypass surgery to complete revascularization for multivessel disease with ten days after the surgical procedure. At the six-month follow-up, one patient had died of cardiogenic shock. Eleven (5%) patients with bail-out procedures underwent coronary bypass surgery or PTCA. Thirty-one patients (31/168) had recurrence of ischemia: 15 patients in the stent group, 11 in SLR group and 5 in the non-SLR group. Re-PTCA was performed in 20 patients, CABG in five and medical therapy in six. Other patients were angina-free at follow-up.
Based on our experience, seeking optimal angiographic results with or without (SLR) stent implantation is a safe and effective operative approach to achieve the best procedural and clinical outcome and reduce complications in patients undergoing PTCA for AMI.
尽管直接经皮冠状动脉腔内血管成形术(PTCA)优于溶栓治疗,但它确实存在一些局限性,包括在住院期间(梗死相关动脉再闭塞导致的反复缺血和再梗死)以及六个月随访时(晚期再狭窄发生率高)。冠状动脉支架置入术是解决其中一些问题的一种有前景的方法,即便其在急性心肌梗死患者中的应用因冠状动脉内血栓形成可能存在争议。在本研究中,我们提出了两种治疗梗死相关动脉(IRA)的手术策略:PTCA后寻求最佳血管造影结果(“支架样结果”——SLR——残余狭窄≤20%——无夹层——心肌梗死溶栓试验(TIMI)3级血流),或在第二次球囊扩张后未获得SLR时进行冠状动脉内支架置入。
1995年12月至1998年5月,200例急性心肌梗死(AMI)患者因溶栓失败接受了直接PTCA或补救性PTCA。其中男性143例,女性57例,平均年龄65岁(范围36 - 84岁)。19例患者发生心源性休克,25例患者Killip分级>Ⅱ级。196例患者(98%)实现了IRA再通。4例患者无法用导丝穿过完全闭塞病变。PTCA后40例患者(20%)获得了SLR。147例患者(75%)置入了支架,其中73处病变为“选择性”植入,原因是41例患者PTCA后结果不理想,33例患者早期出现血管丢失或冠状动脉夹层伴威胁性闭塞。9例未获得SLR的患者因IRA弥漫性病变未进行支架置入。住院期间并发症包括10例死亡(19例入院时心源性休克患者中的8例以及2例多支血管病变和严重左心室功能障碍患者)。没有患者因手术并发症需要急诊冠状动脉搭桥术。1例患者在补救性支架置入术后第三天发生亚急性血栓形成(再次PTCA)。5例患者在手术后十天因多支血管病变需要选择性搭桥手术以完成血运重建。在六个月随访时,1例患者死于心源性休克。11例(5%)接受补救性手术的患者接受了冠状动脉搭桥手术或PTCA。31例患者(31/168)出现缺血复发:支架组15例,SLR组11例,非SLR组5例。20例患者接受了再次PTCA,5例接受了冠状动脉旁路移植术(CABG),6例接受了药物治疗。其他患者在随访时无心绞痛症状。
基于我们的经验,无论是否植入支架(SLR)寻求最佳血管造影结果,对于接受AMI的PTCA患者而言,都是一种安全有效的手术方法,可实现最佳的手术和临床结局并减少并发症。